Mingfeng Han
Impact in
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Medical Research and Treatments
- Traditional Chinese Medicine Analysis
Papers in
-
- COVID-19 Clinical Research Studies 18
- SARS-CoV-2 and COVID-19 Research 3
-
- Medical Research and Treatments 3
- Co-authors
- Xiuyong Li (6 shared papers)Wei Sun (2 shared papers)Xiaoling Xu (1 shared paper)Yun Yang (1 shared paper)Aijun Pan (1 shared paper)Dongsheng Wang (1 shared paper)Tiantian Li (1 shared paper)Xiaohu Zheng (1 shared paper)
- Journals
- Frontiers in Medicine (3 papers)Phytomedicine (3 papers)Aging (2 papers)Journal of Inflammation Research (2 papers)Frontiers in Pharmacology (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Mingfeng Han
30 papers receiving 5k citations
Mingfeng Han's Hit Papers
Peers
Comparison fields: 5 of 143
- Infectious Diseases 3.6k
- Complementary and alternative medicine 237
- Clinical Psychology 493
- General Dentistry 7
- Modeling and Simulation 60
Countries citing papers authored by Mingfeng Han
This map shows the geographic impact of Mingfeng Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingfeng Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingfeng Han more than expected).
Fields of papers citing papers by Mingfeng Han
This network shows the impact of papers produced by Mingfeng Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingfeng Han. The network helps show where Mingfeng Han may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingfeng Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effective treatment of severe COVID-19 patients with tocilizumab Hit paper breakdown → | 2020 | 2107 |
| 2 | Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial Hit paper breakdown → | 2020 | 867 |
| 3 | 2020 | 786 | |
| 4 | [Mental health survey of medical staff in a tertiary infectious disease hospital for COVID-19]. Hit paper breakdown → | 2020 | 528 |
| 5 | 2020 | 368 | |
| 6 | 2020 | 170 | |
| 7 | 2021 | 65 | |
| 8 | 2021 | 35 | |
| 9 | 2020 | 25 | |
| 10 | 2018 | 23 | |
| 11 | 2020 | 22 | |
| 12 | 2020 | 21 | |
| 13 | 2020 | 18 | |
| 14 | 2020 | 16 | |
| 15 | 2020 | 15 | |
| 16 | 2022 | 15 | |
| 17 | 2021 | 13 | |
| 18 | 2021 | 11 | |
| 19 | 2021 | 10 | |
| 20 | 2023 | 7 |
About Mingfeng Han
Mingfeng Han is a scholar working on Infectious Diseases, Complementary and alternative medicine, Pulmonary and Respiratory Medicine, Pharmacology and Pathology and Forensic Medicine, having authored 36 papers that have together received 5.2k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (18 papers), Medical Research and Treatments (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers), Whipple's Disease and Interleukins (2 papers), Analytical Methods in Pharmaceuticals (1 paper), Artificial Intelligence in Healthcare and Education (1 paper) and Inflammatory mediators and NSAID effects (1 paper). The work is most often cited by research in Infectious Diseases (3.6k citations), Complementary and alternative medicine (237 citations), Clinical Psychology (493 citations), General Dentistry (7 citations) and Modeling and Simulation (60 citations). Mingfeng Han has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Xiuyong Li, Wei Sun, Xiaoling Xu, Yun Yang, Aijun Pan, Dongsheng Wang, Tiantian Li, Xiaohu Zheng, Haiming Wei and Yonggang Zhou. Their work appears in journals such as Frontiers in Medicine, Phytomedicine, Aging, Journal of Inflammation Research and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.